Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05571072 · ClinicalTrials.gov registry record · NA
Opioid Use After Urogynecologic Procedures: Using a Predictive Calculator
A NA study, sponsored by David Sheyn.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT05571072 is a NA study that has completed, run by David Sheyn. The registered enrollment target is 110 participants.
The verdict
NCT05571072, a NA study, has completed, sponsored by David Sheyn.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the investigators can precisely predict how much pain medication the subjects will need after surgery using a special calculator that was developed for this purpose.
Interventions
- OTHER Opioid calculator
- OTHER Standard opioid prescription
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2023-01-02 |
| Est. Completion | 2024-02-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05571072
The ClinicalTrials.gov registry entry for NCT05571072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Sheyn, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Opioid calculator is the first listed.
NCT05571072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05571072 about?
NCT05571072 is a clinical study titled "Opioid Use After Urogynecologic Procedures: Using a Predictive Calculator". The purpose of this study is to determine if the investigators can precisely predict how much pain medication the subjects will need after surgery using a special calculator that was developed for this purpose.
What is the current status of trial NCT05571072?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2023-01-02. Estimated completion is 2024-02-17.
What interventions are being tested in trial NCT05571072?
The interventions under investigation include: Opioid calculator (OTHER), Standard opioid prescription (OTHER).
Who is sponsoring clinical trial NCT05571072?
This trial is sponsored by David Sheyn, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.